Harvard researchers say they have discovered a new approach that could “drastically simplify” the process of designing drug cocktails to battle everything from bacterial infection to cancer and even HIV.
As described in a paper published in the July 24 issue of the Proceedings of the National Academy of Sciences, a research team led by Philippe Cluzel, professor of molecular and cellular biology and Gordon McKay Professor of Applied Physics,
Read more...
